0001209191-16-090832.txt : 20160111 0001209191-16-090832.hdr.sgml : 20160111 20160111203555 ACCESSION NUMBER: 0001209191-16-090832 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160111 FILED AS OF DATE: 20160111 DATE AS OF CHANGE: 20160111 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ADURO BIOTECH, INC. CENTRAL INDEX KEY: 0001435049 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 626 BANCROFT WAY STREET 2: SUITE 3-C CITY: BERKELEY STATE: CA ZIP: 94710 BUSINESS PHONE: 510-848-4400 MAIL ADDRESS: STREET 1: 626 BANCROFT WAY STREET 2: SUITE 3-C CITY: BERKELEY STATE: CA ZIP: 94710 FORMER COMPANY: FORMER CONFORMED NAME: ADURO BIOTECH DATE OF NAME CHANGE: 20080514 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Brockstedt Dirk G. CENTRAL INDEX KEY: 0001635616 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37345 FILM NUMBER: 161337510 MAIL ADDRESS: STREET 1: C/O ADURO BIOTECH, INC. STREET 2: 626 BANCROFT WAY, 3C CITY: BERKELEY STATE: CA ZIP: 94710 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2016-01-11 0 0001435049 ADURO BIOTECH, INC. ADRO 0001635616 Brockstedt Dirk G. C/O ADURO BIOTECH, INC. 626 BANCROFT WAY, 3C BERKELEY CA 94710 0 1 0 0 Sr. VP of Research and Dev. Common Stock 2016-01-11 4 M 0 956 1.45 A 12956 D Common Stock 2016-01-11 4 S 0 956 23.51 D 12000 D Common Stock 2016-01-11 4 M 0 21044 0.45 A 33044 D Common Stock 2016-01-11 4 S 0 18638 21.57 D 14406 D Common Stock 2016-01-11 4 S 0 1706 22.40 D 12700 D Common Stock 2016-01-11 4 S 0 700 23.29 D 12000 D Stock Option (Right to Buy) 1.45 2016-01-11 4 M 0 956 0.00 D 2025-01-09 Common Stock 956 290106 D Stock Option (Right to Buy) 0.45 2016-01-11 4 M 0 21044 0.00 D 2020-03-18 Common Stock 21044 51195 D The sales reported in this Form 4 were affected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 13, 2015. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.00 to $22.00, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.01 to $23.00, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.10 to $23.51, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. The shares subject to the Option vest in 48 equal monthly installments from the vesting commencement date of January 10, 2015. The shares subject to the Option are fully vested and immediately exercisable. /s/ Jennifer Lew, Attorney-in-Fact 2016-01-11